New research from a randomized clinical trial provides the strongest long-term evidence yet comparing partial (PKR) and total (TKR) knee replacements for patients with osteoarthritis. Published in The Lancet Rheumatology, the study shows both PKR and TKR being equally effective and offering similar clinical outcomes.
In 2019, the Total or Partial Knee Arthroplasty Trial (TOPKAT) study, led by researchers at NDORMS, found that after 5 years, partial knee replacement (PKR) showed similar, if not better, outcomes than total replacement (TKR). But the research horizon was extended to ten years to study whether the longer-term quality of life outlook for patients could be assessed.
Now, with 10 years of data, researchers have found that patients who underwent PKR and TKR had similar long-term pain relief, function, and quality of life outcomes.









